Certified Post Anesthesia Nurse (CPAN) Practice Exam

Opioid reversal agents, such as naloxone, are utilized in post-anesthesia care to counteract the effects of opioids, especially when excessive sedation or respiratory depression is observed. A well-recognized side effect of these reversal agents is the induction of withdrawal symptoms in patients who are opioid-dependent. This occurs because the reversal agent rapidly displaces the opioid from its receptors, which can lead to a sudden onset of withdrawal symptoms, such as agitation, nausea, vomiting, and increased heart rate, among others. Withdrawal symptoms arise because, when the opioid’s effects are quickly blocked, the individual’s body, which has adapted to the presence of the drug, reacts negatively to its absence. Understanding this consequence is critical in managing patient care during the recovery phase, allowing healthcare providers to anticipate and address the discomfort associated with withdrawal in patients who have developed a tolerance or dependency on opioids. In terms of the other options, while increased blood pressure and heightened pain perception may occur as a result of opioid reversal, they are not as directly associated with the core pharmacological action of these agents as withdrawal symptoms are. Enhanced sedation is also not expected, as reversal agents are intended to counteract sedation. Thus, the induction of withdrawal symptoms stands out